Concomitant monitoring of WT1 and FLT3-ITD expression in FLT3-ITD acute myeloid leukemia patients: which should we trust as a minimal residual disease marker?
about
Concomitant monitoring of WT1 and FLT3-ITD expression in FLT3-ITD acute myeloid leukemia patients: which should we trust as a minimal residual disease marker?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Concomitant monitoring of WT1 ...... nimal residual disease marker?
@en
Concomitant monitoring of WT1 ...... nimal residual disease marker?
@nl
type
label
Concomitant monitoring of WT1 ...... nimal residual disease marker?
@en
Concomitant monitoring of WT1 ...... nimal residual disease marker?
@nl
prefLabel
Concomitant monitoring of WT1 ...... nimal residual disease marker?
@en
Concomitant monitoring of WT1 ...... nimal residual disease marker?
@nl
P2093
P2860
P356
P1476
Concomitant monitoring of WT1 ...... nimal residual disease marker?
@en
P2093
Anna Candoni
Bonnie Wing Yin Lau
Lisa Haley
Maria Elena Zannier
Renato Fanin
P2860
P304
P356
10.1002/AJH.24686
P577
2017-03-22T00:00:00Z